← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2013Last known activity
Jun 6, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT05595538CollaboratorEarly Phase 1Jun 6, 2020
- NCT05595538Overall official - principal investigatorEarly Phase 1Jun 6, 2020
- NCT05595538OfficialEarly Phase 1Jun 6, 2020
- NCT02307201Reponsible party - principal investigatorPhase 2/Phase 3Dec 1, 2014
- NCT02307201Overall official - principal investigatorPhase 2/Phase 3Dec 1, 2014
- NCT02307201Lead sponsorPhase 2/Phase 3Dec 1, 2014
- NCT02317146Lead sponsorPhase 2/Phase 3Nov 1, 2013
- NCT02317146Reponsible party - principal investigatorPhase 2/Phase 3Nov 1, 2013
- NCT01988298Lead sponsorPhase 2/Phase 3Oct 1, 2013
- NCT01988298Reponsible party - principal investigatorPhase 2/Phase 3Oct 1, 2013
Details
- Last known activity
- Jun 6, 2020